Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

Health systems are seeking payment increases to shore up finances that have been hit hard by COVID-19 and rising labor costs. We identified key considerations for insurers as they enter these negotiations.

Partner, Health Services, Oliver Wyman

As social determinants of health become a common conversation in healthcare, loneliness and social isolation are rising to the forefront.

Founder and Ceo, Papa

Omnichannel care is here to stay, forcing health systems to keep pace with a variety of consumer-centric competitors. We’ve identified three approaches health systems can take to ensure their technology stack is built for success.

Principal, Digital and Health and Life Sciences, Oliver Wyman
Partner, Digital and Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

The increased need for behavioral healthcare is putting pressure on a system that is ill-prepared to deal with an influx of patients.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

NorthShore – Edward-Elmhurst Health has an ambitious program to integrate genomics into primary care. The results so far are positive, with 95% of NorthShore primary care doctors utilizing genomics in their practice.

Chief Innovation and Transformation Officer, NorthShore – Edward-Elmhurst Health

Insights in your inbox

Subscribe

The spike in virtual care over the past two years opens the door for healthcare organizations to improve the payment journey.

Principal, Financial Services, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

New standards for data interoperability could redefine the value proposition for payers, providers, and patients.

Chief Strategy Officer, 1upHealth

Cell and gene therapies hold tremendous promise for patients and the industry, but new business models are needed to get innovations to patients.

Principal, Health and Life Sciences, Oliver Wyman

Using health IT to tackle health equity and opening multiple front doors for patients were a couple of themes that emerged at three big health conferences.

Senior Editor, Health and Life Sciences, Oliver Wyman

As the Biden administration leans into the Cancer Moonshot 2.0, the life sciences industry has the opportunity to launch a new era of precision oncology. How can we accelerate progress toward truly personalized medicine and revolutionize cancer care?

President and CEO, COTA, Inc.

Insights in your inbox

Subscribe